Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: Role, controversies and approach to diagnosis

Cytopathology

Volumn 22, Issue 5, 2011, Pages 287-305

  Wee, A ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cell block; Cytology; Dysplastic nodules; Fine needle aspiration biopsy; Hepatocellular carcinoma; Hepatocellular nodular lesions; Immunohistochemistry; Liver; Microbiopsy; Needle tract seeding

Indexed keywords

ALGORITHM; ASPIRATION BIOPSY; BILE DUCT CARCINOMA; CANCER CYTODIAGNOSIS; CANCER RISK; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; LIVER NODULE; NODULAR HYPERPLASIA; NOMENCLATURE; PRIORITY JOURNAL; REVIEW; TUMOR SEEDING; TUMOR VOLUME;

BIOPSY, FINE-NEEDLE; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HUMANS; INDIVIDUALIZED MEDICINE; LIVER NEOPLASMS; LYMPH NODES; NEOPLASM METASTASIS; NEOPLASMS;

EID: 80052969892     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2011.00882.x     Document Type: Review

References (99)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Wörns M, Galle P. Future perspectives in hepatocellular carcinoma. Dig Liver Dis 2010;42 (Suppl. 3):S302-9.
3. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-30.
4. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
5. Wang P, Meng ZQ, Chen Z et al. Diagnostic value and complications of fine needle aspiration for primary liver cancer and its influence on the treatment outcome. A study based on 3011 patients in China. Eur J Surg Oncol 2008;34:541-6.
6. Caturelli E, Ghittoni G, Roselli P, De Palo M, Anti M. Fine needle biopsy of focal liver lesions: the hepatologist's point of view. Liver Transpl 2004;10 (2 Suppl. 1):S26-9.
7. Durand F, Belghiti J, Paradis V. Liver transplantation for hepatocellular carcinoma: role of biopsy. Liver Transpl 2007;13 (11 Suppl. 2):S17-23.
8. Scholmerich J, Schacherer D. Diagnostic biopsy for hepatocellular carcinoma in cirrhosis: useful, necessary, dangerous, or academic sport? Gut 2004;53:1224-6.
9. Roncalli M, Park YN, Di Tommaso L. Histopathological classification of hepatocellular carcinoma. Dig Liver Dis 2010;42(Suppl. 3):S228-34.
10. Roskams T, Kojiro M. Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin Liver Dis 2010;30:17-25.
11. Caturelli E, Solmi L, Anti M et al. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 2004;53:1356-62.
12. Torzilli G, Minagawa M, Takayama T et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999;30:889-93.
13. Durand F, Regimbeau JM, Belghiti J et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001;35:254-8.
14. Fornari F, Civardi G, Cavanna L et al. Complications of ultrasonically guided fine-needle abdominal biopsy. Results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group. Scand J Gastroenterol 1989;24:949-55.
15. Stigliano R, Marelli L, Yu D et al. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007;33:437-47.
16. Tung WC, Huang YJ, Leung SW et al. Incidence of needle tract seeding and responses of soft tissue metastasis by hepatocellular carcinoma postradiotherapy. Liver Int 2007;27:192-200.
17. Saborido BP, Diaz JC, de Los Galanes SJ et al. Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma? Transplant Proc 2005;37:3874-7.
18. de Boer WB, Segal A, Frost FA, Sterrett GF. Cytodiagnosis of well differentiated hepatocellular carcinoma: can indeterminate diagnoses be reduced? Cancer 1999;87:270-7.
19. Wee A, Nilsson B. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy?? Acta Cytol 2003;47:16-26.
20. Hertz G, Reddy VB, Green L et al. Fine-needle aspiration biopsy of the liver: a multicenter study of 602 radiologically guided FNA. Diagn Cytopathol 2000;23:326-8.
21. Kuo FY, Chen WJ, Lu SN, Wang JH, Eng HL. Fine needle aspiration cytodiagnosis of liver tumors. Acta Cytol 2004;48:142-8.
22. Crowe DR, Eloubeidi MA, Chhieng DC et al. Fine-needle aspiration biopsy of hepatic lesions: computerized tomographic-guided versus endoscopic ultrasound guided FNA. Cancer 2006;108:180-5.
23. DeWitt J, LeBlanc J, McHenry L et al. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience. Am J Gastroenterol 2003;98:1976-81.
24. Singh P, Erickson RA, Mukhopadhyay P et al. EUS for detection of the hepatocellular carcinoma: results of a prospective study. Gastrointest Endosc 2007;66:265-73.
25. Singh P, Mukhopadhyay P, Bhatt B et al. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: results of a prospective comparative study. J Clin Gastroenterol 2009;43:367-73.
26. Awad SS, Fagan S, Abudayyeh S et al. Preoperative evaluation of hepatic lesions for the staging of hepatocellular and metastatic liver carcinoma using endoscopic ultrasonography. Am J Surg 2002;184:601-4.
27. Maheshwari A, Kantsevoy S, Jagannath S, Thuluvath PJ. Endoscopic ultrasound and fine-needle aspiration for the diagnosis of hepatocellular carcinoma. Clin Liver Dis 2010;14:325-32.
28. Wee A. Fine needle aspiration biopsy of the liver: algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma. Cytojournal 2005;2:7.
29. Eloubeidi MA, Tamhane A, Jhala N et al. Agreement between rapid onsite and final cytologic interpretations of EUS-guided FNA specimens: implications for the endosonographer and patient management. Am J Gastroenterol 2006;101:2841-7.
30. Pupulim LF, Felce-Dachez M, Paradis V et al. Algorithm for immediate cytologic diagnosis of hepatic tumors. AJR Am J Roentgenol 2008;190:W208-12.
31. Khurana U, Handa U, Mohan H, Sachdev A. Evaluation of aspiration cytology of the liver space occupying lesions by simultaneous examination of smears and cell blocks. Diagn Cytopathol 2009;37:557-63.
32. Longchampt E, Patriarche C, Fabre M. Accuracy of cytology vs. microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule. Definition of standardized criteria from a study of 100 cases. Acta Cytol 2000;44:515-23.
33. Hoda RS. Non-gynaecologic cytology on liquid-based preparations. A morphologic view of facts and artifacts. Diagn Cytopathol 2007;35:621-34.
34. Michael CW, Hunter B. Interpretation of fine-needle aspirates processed by the ThinPrep technique: cytologic artifacts and diagnostic pitfalls. Diagn Cytopathol 2000;23:6-13.
35. Fadda G, Rossi ED, Mulè A et al. Diagnostic efficacy of immunocytochemistry on fine needle aspiration biopsies processed by thin-layer cytology. Acta Cytol 2006;50:129-35.
36. Maturen KE, Nghiem HV, Marrero JA et al. Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol 2006;187:1184-7.
37. Chapoutot C, Perney P, Fabre D et al. Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients. Gastroenterol Clin Biol 1999;23:552-6.
38. Ng KK, Poon RT, Lo CM et al. Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center. Arch Surg 2004;139:193-200.
39. Hemming AW, Cattral MS, Reed AI et al. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-9.
40. Stigliano R, Burroughs AK. Should we biopsy each liver mass suspicious for HCC before liver transplantation? - no, please don't. J Hepatol 2005;43:563-8.
41. Bosman FT, Carneiro F, Hruban RH, Theise ND (eds). WHO Classification of Tumours of the Digestive System. Lyon: IARC; 2010.
42. Hytiroglou P, Park YN, Krinsky G, Theise ND. Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am 2007;36:867-87.
43. International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 2009;49:658-64.
44. Le Bail B, Bernard PH, Carles J, Balabaud C, Bioulac-Sage P. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol 1997;27:835-42.
45. Zhang J, Krinsky GA. Iron-containing nodules of cirrhosis. NMR Biomed 2004;17:459-64.
46. Krinsky GA, Lee VS, Nguyen MT et al. Siderotic nodules at MR imaging: regenerative or dysplastic? J Comput Assist Tomogr 2000;24:773-6.
47. Deugnier YD, Charalambous P, Le Quilleuc D et al. Preneoplastic significance of hepatic iron-free foci in genetic haemochromatosis: a study of 185 patients. Hepatology 1993;18:1363-9.
48. Yang BH, Xia JL, Huang LW et al. Changes of clinical aspect of primary liver cancer in China during the past 30years - control study for 3, 250 cases with primary liver cancer. Natl Med J China 2003;83:1053-7.
49. Forner A, Reig M, Bruix J. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star. Gastroenterology 2009;137:26-9.
50. Wee A, Sampatanukul P. Fine Needle Aspiration Cytology of the Liver. Diagnostic Algorithms. A Southeast Asian Perspective. Bangkok: Year Book Publisher Co Ltd; 2004.
51. Ruschenburg I, Droese M. Fine needle aspiration cytology of focal nodular hyperplasia of the liver. Acta Cytol 1989;33:857-60.
52. Lin CC, Lin CJ, Hsu CW et al. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades. J Gastroenterol Hepatol 2008;23:146-52.
53. Soyuer I, Ekinci C, Kaya M, Genc Y, Bahar K. Diagnosis of hepatocellular carcinoma by fine needle aspiration cytology. Cellular features. Acta Cytol 2003;47:581-9.
54. Bergman S, Graeme-Cook F, Pitman MB. The usefulness of the reticulin stain in the differential diagnosis of liver nodules on fine-needle aspiration biopsy cell block preparations. Mod Pathol 1997;10:1258-64.
55. Zeppa P, Anniciello A, Vetrani A, Palombini L. Fine needle aspiration biopsy of hepatic focal fatty change. A report of two cases. Acta Cytol 2002;46:567-70.
56. Singh HK, Silverman JF, Geisinger KR. Fine-needle aspiration cytomorphology of clear-cell hepatocellular carcinoma. Diagn Cytopathol 1997;17:306-10.
57. Piatti B, Caspani B, Giudici C, Ferrario D. Fine needle aspiration biopsy of hepatocellular carcinoma resembling neuroendocrine tumor. A case report. Acta Cytol 1997;41:583-6.
58. Wee A, Nilsson B, Yap I. Fine needle aspiration biopsy of small/intermediate cell tumors in the liver. Considerations in a Southeast Asian population. Acta Cytol 1996;40:937-47.
59. Maeda T, Adachi E, Kajiyama K et al. Spindle cell hepatocellular carcinoma: a clinicopathologic and immunohistochemical analysis of 15 cases. Cancer 1996;77:51-7.
60. Durnez A, Verslype C, Nevens F et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma: a possible progenitor cell origin. Histopathology 2006;49:138-51.
61. Kunz G Jr, Chung J, Ali SZ. Hepatocellular carcinoma-fibrolamellar variant: cytopathology of an unusual case. Diagn Cytopathol 2002;26:257-61.
62. Pérez-Guillermo M, Masgrau NA, García-Solano J, Sola-Pérez J, de Augustin y de Augustin P. Cytologic aspect of fibrolamellar hepatocellular carcinoma in fine-needle aspirates. Diagn Cytopathol 1999;21:180-7.
63. Dusenbery D. Combined hepatocellular-cholangiocarcinoma: cytologic findings in four cases. Acta Cytol 1997;41:903-9.
64. Wee A, Nilsson B. Combined hepatocellular-cholangiocarcinoma. Diagnostic challenge in hepatic fine needle aspiration biopsy. Acta Cytol 1999;43:131-8.
65. Takenaka A, Kaji I, Kasugai H et al. Usefulness of diagnostic criteria for aspiration cytology of hepatocellular carcinoma. Acta Cytol 1999;43:610-6.
66. Alatassi H, Sahoo S. Epithelioid angiomyolipoma of the liver with striking giant cell component: fine-needle aspiration biopsy findings of a rare neoplasm. Diagn Cytopathol 2009;37:192-4.
67. Cha I, Cartwright D, Guis M, Miller TR, Ferrell LD. Angiomyolipoma of the liver in fine-needle aspiration biopsies: its distinction from hepatocellular carcinoma. Cancer 1999;87:25-30.
68. Khalbuss WE, Fischer G, Bazooband A. Imprint cytology of epithelioid hepatic angiomyolipoma: mimicry of hepatocellular carcinoma. Acta Cytol 2007;51:670-2.
69. Lupovitch A, Chen R, Mishra S. Inflammatory pseudotumor of the liver. Report of the fine needle aspiration cytologic findings in a case initially misdiagnosed as malignant. Acta Cytol 1989;33:259-62.
70. Jackson SB, Williams HJ. Fine-needle aspiration cytology of metastatic carcinoid tumor: report of a case and review of the literature. Diagn Cytopathol 2003;28:49-53.
71. Rappaport KM, DiGiuseppe JA, Busseniers AE. Primary hepatic lymphoma: report of two cases diagnosed by fine-needle aspiration. Diagn Cytopathol 1995;13:142-5.
72. Dong Q, McKee G, Pitman M, Geisinger K, Tambouret R. Epithelioid variant of gastrointestinal stromal tumor: diagnosis by fine-needle aspiration. Diagn Cytopathol 2003;29:55-60.
73. Wee A, Nilsson B. Fine needle aspiration biopsy of hepatic leiomyosarcoma: an unusual epithelioid variant posing a potential diagnostic pitfall in a hepatocellular carcinoma-prevalent population. Acta Cytol 1997;41:737-43.
74. Wee A, Thamboo TP, Thomas A. alpha-Fetoprotein-producing liver carcinomas of primary extrahepatic origin. Acta Cytol 2003;47:799-808.
75. Kakar S, Gown AM, Goodman ZD, Ferrell LD. Best practices in diagnostic immunohistochemistry. Arch Pathol Lab Med 2007;131:1648-54.
76. Wee A. Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics. Appl Immunohistochem Mol Morphol 2006;14:266-72.
77. Lau SK, Prakash S, Geller SA, Alsabeh R. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 2002;33:1175-81.
78. Minervini M, Demetris A, Lee R et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686-92.
79. Morrison C, Marsh W Jr, Frankel WL. A comparison of CD10 to pCEA, MOC-31 and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol 2002;15:1279-87.
80. Saad RS, Luckasevic TM, Noga CM et al. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Diagn Cytopathol 2004;30:1-6.
81. Wang L, Vuolo M, Suhrland MJ, Schlesinger K. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates. Acta Cytol 2006;50:257-62.
82. Ahuja A, Gupta N, Kalra N et al. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver. Cytopathology 2008;19:229-35.
83. Saleh HA, Aulicino M, Zaidi SY, Khan AZ, Masood S. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel. Diagn Cytopathol 2009;37:184-90.
84. Gokden M, Shinde A. Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver. Diagn Cytopathol 2005;33:166-72.
85. Fan Z, van de Rijn M, Montgomery K, Rouse RV. Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003;16:137-44.
86. Siddiqui MT, Saboorian MH, Gokaslan ST, Ashfaq R. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Cancer 2002;96:49-52.
87. Lugli A, Tornilli L, Mirlacher M et al. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues. Tissue microarray analysis on 3, 940 tissue samples. Am J Clin Pathol 2004;122:721-7.
88. Villari D, Caruso R, Gross M et al. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study. Pathology 2002;34:423-6.
89. Lei JY, Bourne PA, diSant'Agnese PA, Huang J. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver. Am J Clin Pathol 2006;125:519-25.
90. Chu P, Wu E, Weiss L. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-72.
91. Kandil D, Leiman G, Allegretta M et al. Glypican-3 immunocytochemistry in liver fine-needle aspirates: a novel stain to assist in the differentiation of benign and malignant liver lesions. Cancer 2007;111:316-22.
92. Nassar A, Cohen C, Siddiqui MT. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies. Diagn Cytopathol 2009;37:629-35.
93. Shafizeh N, Ferrell LD, Kakar S. Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum. Mod Pathol 2008;21:1011-8.
94. Ligato S, Mandich D, Cartun RW. Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study. Mod Pathol 2008;21:626-31.
95. Capurro M, Wanless I, Sherman M et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003;125:89-97.
96. Chuma M, Sakamoto M, Yamazaki K et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2003;37:198-207.
97. Di Tommaso L, Destro A, Seok JY et al. The application of markers (HSP70, GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol 2009;50:746-54.
98. Osada T, Nagashima I, Tsuno NH, Kitayama J, Nagawa H. Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma. J Hepatol 2000;33:247-53.
99. Bioulac-Sage P, Laumonier H, Rullier A et al. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 2009;29:459-65.